Winthrop Advisory Group LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 1 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Winthrop Advisory Group LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,998
-53.9%
10,0000.0%0.00%
-50.0%
Q2 2023$13,000
-26.1%
10,0000.0%0.00%
-33.3%
Q1 2023$17,600
-43.9%
10,0000.0%0.00%
-50.0%
Q4 2022$31,400
-35.9%
10,0000.0%0.01%
-40.0%
Q3 2022$49,000
+19.5%
10,0000.0%0.01%0.0%
Q2 2022$41,000
-29.3%
10,0000.0%0.01%
-16.7%
Q1 2022$58,000
-22.7%
10,0000.0%0.01%
-20.0%
Q4 2021$75,000
-16.7%
10,0000.0%0.02%
-25.0%
Q3 2021$90,000
-25.0%
10,000
-0.5%
0.02%
-25.9%
Q2 2021$120,000
-4.0%
10,050
+0.5%
0.03%
-12.9%
Q1 2021$125,00010,0000.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders